Key result
Natural bioactive compounds target hypercholesterolemia primarily via NPC1L1 inhibition, accounting for ~37% of studied mechanisms.
Why the study?
Statins are the cornerstone of hypercholesterolemia treatment, but long-term use is often limited by side effects such as myopathy and hepatotoxicity, motivating evaluation of natural bioactive compounds and their protein targets as alternative regulators of cholesterol homeostasis.
Do natural bioactive compounds derived from medicinal plants and foods improve cholesterol homeostasis by modulating key protein targets in hypercholesterolemia?
Do natural bioactive compounds derived from medicinal plants and foods improve cholesterol homeostasis by modulating key protein targets in hypercholesterolemia?
This narrative review highlights the molecular mechanisms of natural bioactive compounds targeting NPC1L1, SREBP-2, HMGCR, and PCSK9, positioning them as promising multi-target complementary or alternative candidates for managing hypercholesterolemia, pending rigorous clinical validation.
Answers are grounded in this paper and cite their sources.
Natural bioactives may support multi-target strategies; leaves open clinical efficacy versus statins pending randomized trials.
Hypercholesterolemia, a condition characterized by elevated cholesterol levels, has been identified as a major risk factor for cardiovascular disease, which is recognized as the leading cause of mortality on a global scale. Whereas statins remain the cornerstone of pharmacological treatment for hypercholesterolemia, their long-term use is often limited by side effects such as myopathy and hepatotoxicity. Natural bioactive compounds derived from medicinal plants and foods have emerged as promising alternatives for treating hypercholesterolemia due to their multi-target mechanisms, reduced side effects, and wide availability. These compounds, including polyphenols, flavonoids, terpenoids, and plant sterols, have demonstrated efficacy in regulating major cholesterol metabolic pathways, such as reducing intestinal cholesterol absorption, inhibiting cholesterol synthesis, regulating transcription factors, and increasing cholesterol excretion. This review discusses the molecular mechanisms through which previous natural compounds regulate cholesterol homeostasis, focusing on their interactions with proteins such as HMGCR, NPC1L1, PCSK9, and the transcription factor SREBP-2.
No takes yet. Share an insight, caveat, or question.
Umar et al. (2026) conducted a review in Hypercholesterolemia. Natural bioactive compounds (polyphenols, flavonoids, terpenoids, and plant sterols) was evaluated on Modulation of cholesterol regulation mechanisms (NPC1L1, SREBP, HMGCR, PCSK9, ACAT2, HMGCS1, MTP). Natural bioactive compounds target hypercholesterolemia primarily via NPC1L1 inhibition, SREBP modulation, HMGCR inhibition, and PCSK9 inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: